Long-Term Cardiovascular Effects of COVID-19

In many places worldwide, the worst part of the pandemic is still to come. Meanwhile, in other areas, the number of cases is rising again. In this context, the long-term effects of COVID-19 are starting to show.

COVID-19 efectos cardiovasculares

Many believe this is not a current issue, but it will definitely be a problem in the future.

It is paramount to detect cardiovascular morbidities and complications in order to mitigate active infections. These include myocarditis, infarction, stroke, venous thromboembolism and multisystem inflammatory syndrome in children.

There is little information about what happens after the acute phase; however, recent publications have begun to shed some light on its impact.

The work done by Dr. Puntmann et al. showed that 78% of adult patients who recovered from COVID-19 presented some type of myocardial involvement. Said involvement was, in most cases, an inflammation diagnosed by magnetic resonance imaging and positive ultra-sensitive troponin. The results derived from magnetic resonance imaging differ from those from autopsies. In the latter, the evidence of myocarditis from COVID-19 is up to 10x lower than in magnetic resonance imaging.


Read also: The Key We Are Overlooking in Peripheral Vascular Disease.


This difference between imaging and anatomical pathology may possibly be caused by overinterpretation of the former, which could be mimicking inflammation. Physiological and technical variables might play a role.

Other coronaviruses, such as SARS and MERS, caused myocarditis in extremely rare cases. Unless this new coronavirus SARS-CoV-2 is functionally different from its predecessors, we should not expect long-term cardiac inflammation.

This pandemic proven the importance of anatomical pathology studies. Quality autopsies made it possible to calibrate clinical, radiological, and laboratory findings during the course of the infection.


Read also: Dietary Supplements and Diets Show No Impact on Cardiovascular Risk.


These autopsies mostly showed that the large number of pathological findings in the cardiovascular system were secondary to inflammation and not directly caused by the virus.

Lastly, the public health risk caused by COVID-19 should be balanced with other more individual aspects of health, such as physical, mental, and emotional wellbeing.

CIRCULATIONAHA-120-051362free

Título original: An Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System.

Referencia: Joseph J. Maleszewski et al. Circulation. 2020 Sep 24. Online before print. DOI: 10.1161/CIRCULATIONAHA.120.051362.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....